M3 Advisory Group LLC Makes New $210,000 Investment in Mettler-Toledo International, Inc. $MTD

M3 Advisory Group LLC acquired a new stake in Mettler-Toledo International, Inc. (NYSE:MTD) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 179 shares of the medical instruments supplier’s stock, valued at approximately $210,000.

Several other institutional investors also recently modified their holdings of the company. Park Avenue Securities LLC lifted its stake in Mettler-Toledo International by 7.2% in the 1st quarter. Park Avenue Securities LLC now owns 297 shares of the medical instruments supplier’s stock valued at $351,000 after purchasing an additional 20 shares during the last quarter. Farther Finance Advisors LLC raised its stake in Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier’s stock valued at $103,000 after buying an additional 25 shares during the period. GAMMA Investing LLC lifted its position in shares of Mettler-Toledo International by 11.2% in the first quarter. GAMMA Investing LLC now owns 327 shares of the medical instruments supplier’s stock valued at $386,000 after buying an additional 33 shares during the last quarter. CX Institutional bought a new position in shares of Mettler-Toledo International during the 1st quarter worth approximately $175,000. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Mettler-Toledo International by 95.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier’s stock worth $2,600,000 after acquiring an additional 1,073 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Down 2.5%

Shares of Mettler-Toledo International stock opened at $1,274.39 on Monday. The stock has a market capitalization of $26.25 billion, a price-to-earnings ratio of 32.27, a price-to-earnings-growth ratio of 3.82 and a beta of 1.37. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,486.76. The company has a 50-day simple moving average of $1,278.97 and a two-hundred day simple moving average of $1,190.01.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the prior year, the business posted $9.65 EPS. The business’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gerry Keller sold 165 shares of the business’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares of the company’s stock, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock worth $2,371,208 in the last 90 days. Company insiders own 0.77% of the company’s stock.

Analysts Set New Price Targets

MTD has been the subject of several research reports. Bank of America raised their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Citigroup raised their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Evercore ISI lifted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Barclays increased their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Finally, JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $1,336.50.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.